ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD. – Trademark Portfolio

Entity Type: 16

ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LIVPAIN. The owner is based in Zhejiang Province.

355 South Changchun Road,Yuyang,Wanquan

Zhejiang Province 325400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LIVPAIN
LIVPAIN
Registered 2022

Trademark Classifications

ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD. have?

ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD. file in?

ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD.'s most well-known trademarks?

ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD.'s registered trademark portfolio includes well-known marks such as LIVPAIN. These are among 1 currently registered trademark in the portfolio.

What is ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD.'s trademark registration success rate?

ZHEJIANG BOFENG ELECTRIC TECHNOLOGY CO.,LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.